跳至主要内容
临床试验/ISRCTN82265570
ISRCTN82265570已完成未知

Modafinil for the treatment of fatigue in lung cancer: a pilot study

Cambridge University Hospitals NHS Foundation Trust (UK)0 个研究点目标入组 208 人开始时间: 2006年4月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
208

研究概览

简要总结

2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19270033 results

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Histologically or cytologically confirmed non-small cell lung cancer (NSCLC)
  • 2. A fatigue score of four using bimodal scoring in the Chalder fatigue scale
  • 3. World Health Organisation (WHO) performance status of 0-3
  • 4. Ability to give informed consent to participate

排除标准

  • 1. Received radiotherapy or chemotherapy within the last four weeks
  • 2. Commenced on antidepressants or steroids (corticosteroids and progestational steroids) within the last two weeks
  • 3. Received blood transfusion within the last two weeks
  • 4. Potentially fertile women of child-bearing age
  • 5. Uncontrolled moderate to severe hypertension, arrhythmia
  • 6. Previous adverse reaction to modafinil or other central nervous system (CNS) stimulant
  • 7. Current active involvement in another clinical trial

研究者

相似试验